ENTROPY NEURODYNAMICS LIMITED — Director's Dealing 2022

Dec 19, 2022

Appendix 3Z Final Director's Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity	Exopharm Limited
ABN	78 163 765 991

We (the entity) give ASX the following information under listing rule 3.19.A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Elizabeth McGregor
Date of last notice	3 September 2021
Date that director ceased to bedirector	20 December 2022

Part 1 - Director's relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Number & class of securities

30,000 - ORDINARY FULLY PAID SHARES

Part 2 - Director's relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of	Number & class of Securities
interest
Note: Provide details of the circumstances
giving rise to the relevant interest.
Nil	Nil

Part 3 - Director's interests in contracts

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if	N/A
issued securities)

• See chapter 19 for defined terms.

11/03/2002

Appendix 3Z Page 1

Appendix 3Z Final Director's Interest Notice

No. and class of securities to N/A which interest relates

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/03/2002